The healthcare industry is ripe for disruptions.
*Stock prices used were the afternoon prices of Sept. 14, 2026. The video was published on Sept. 16, 2026.
Should you buy stock in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, it’s worth evaluating the company’s fundamentals, growth trajectory, and current valuation against the broader healthcare landscape.
The Motley Fool’s Stock Advisor service has delivered an average return of 938% — significantly outperforming the S&P 500’s 211% over the same period.*
*Stock Advisor returns as of September 16, 2026.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy.
Also Read
- Global Cities Index 2026: Europe and the US Lead Rankings While Highlighting Distinct Strengths and Challenges
- Mahsa Amini’s Enduring Legacy: Four Years After Her Death, Iran’s Protests Persist
- Australian Shares Edge Higher After Early Gains Fade, Led by Mining and Energy
- EU chief sets out her vision for Europe’s future in a key speech watched by Canada’s Mark Carney